Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Okada

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Npj Metabolic Health and Disease|July 1, 2026
Metabolic reprogramming in polyol pathway contributes to anti-inflammatory effect of glucosamine salts on synovial fibroblastsJunichi Okada, Rei Nakano, Nanako Kitanaka, et al.
Endocrine Journal|January 7, 2021
In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose controlTakuya Watanabe, Yuichi Temma, Junichi Okada, et al.
The Journal of Pharmacy and Pharmacology|July 29, 2010
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liverMotoko Saito-Yabe, Yuji Kasuya, Yasushi Yoshigae, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
A novel subset of hepatocytes is simultaneously gluconeogenic and <i>de novo</i> lipogenic in the fed state and is naturally insulin resistantJunichi Okada, Austin Landgraf, Maxwell Horton, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Npj Metabolic Health and Disease|July 1, 2026
Metabolic reprogramming in polyol pathway contributes to anti-inflammatory effect of glucosamine salts on synovial fibroblastsJunichi Okada, Rei Nakano, Nanako Kitanaka, et al.
Endocrine Journal|January 7, 2021
In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose controlTakuya Watanabe, Yuichi Temma, Junichi Okada, et al.
The Journal of Pharmacy and Pharmacology|July 29, 2010
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liverMotoko Saito-Yabe, Yuji Kasuya, Yasushi Yoshigae, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
A novel subset of hepatocytes is simultaneously gluconeogenic and <i>de novo</i> lipogenic in the fed state and is naturally insulin resistantJunichi Okada, Austin Landgraf, Maxwell Horton, et al.
Pageof 7